Kv1.3
New VRG Tx patent application filed!

We are thrilled to announce the filing of our broad-spectrum composition of matter patent application for our Kv1.3 project (VRG-K1). This significant milestone – given the advanced preclinical stage of our project – ensures lasting IP protection and brings us one step closer to making a positive impact on human health.

Our innovative Kv1.3 asset is designed to enable effective T cell inhibition, precisely targeting a specific subpopulation of T cells while sparing the broader immune system. The efficacy of our compound is backed by strong in vivo proof of concept studies. Moreover, this filing highlights the improved developability of our novel characterized compounds, marking a significant step forward in our journey to bring cutting-edge solutions to the market.

VRG-K1 will be utilized to treat chronic inflammatory diseases such as atopic dermatitis, opening up new possibilities for providing relief to millions of patients suffering from these debilitating conditions.

Stay tuned for more updates as we continue to push the boundaries of innovation!

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
July 11, 2024
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
July 11, 2024
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
Infrastructure
September 4, 2024
By VRG Therapeutics
VRG Therapeutics is expanding into the Netherlands!
White arrow icon up and right direction redirecting to Partner with US page
AI
Team
July 29, 2024
By VRG Therapeutics
VRG Therapeutics has been selected among the "Early Stage Startups to Watch" in the drug discovery space by Sifted!
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
Infrastructure
September 4, 2024
By VRG Therapeutics
VRG Therapeutics is expanding into the Netherlands!
White arrow icon up and right direction redirecting to Partner with US page
AI
Team
July 29, 2024
By VRG Therapeutics
VRG Therapeutics has been selected among the "Early Stage Startups to Watch" in the drug discovery space by Sifted!
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life